Top compounds associated with response to TMEM33


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.00062 1
mRNA ciclosporin CTRPv2 pan-cancer AAC 0.00068 1
mRNA MS-275 FIMM pan-cancer AAC -0.0026 1
mRNA BIRB 0796 FIMM pan-cancer AAC 0.0033 1
mRNA Methotrexate FIMM pan-cancer AAC -0.0019 1
mRNA AZD6244 FIMM pan-cancer AAC -0.00011 1
Download CSV